Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAND
2151
Gladstone Land Corp
LAND
$352M
| $7.43M | ﹤0.01% |
220,037
+19,640
| +10% | +$529K |
|
2152
AngioDynamics
ANGO
$619M
| $7.42M | ﹤0.01% |
269,050
+5,143
| +2% | +$142K |
|
2153
Nabors Industries
NBR
$1.23B
| $7.38M | ﹤0.01% |
90,986
-4,903
| -5% | -$483K |
|
2154
Inovio Pharmaceuticals
INO
$58M
| $7.36M | ﹤0.01% |
122,976
+2,086
| +2% | +$167K |
|
2155
Madrigal Pharmaceuticals
MDGL
$10.9B
| $7.35M | ﹤0.01% |
86,718
+3,850
| +5% | +$316K |
|
|
AD
2156
Array Digital Infrastructure
AD
$3.02B
| $7.34M | ﹤0.01% |
232,951
+13,099
| +6% | +$413K |
|
2157
StoneX
SNEX
$9.23B
| $7.33M | ﹤0.01% |
606,209
+9,381
| +2% | +$123K |
|
2158
Hydrofarm Holdings
HYFM
$10.1M
| $7.33M | ﹤0.01% |
25,916
+425
| +2% | +$144K |
|
2159
MacroGenics
MGNX
$236M
| $7.32M | ﹤0.01% |
456,194
+6,164
| +1% | +$116K |
|
2160
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $7.32M | ﹤0.01% |
260,524
+3,241
| +1% | +$91.9K |
|
2161
Pulmonx
LUNG
$81.9M
| $7.32M | ﹤0.01% |
228,239
+6,373
| +3% | +$233K |
|
2162
Koppers
KOP
$968M
| $7.32M | ﹤0.01% |
233,764
-37,110
| -14% | -$1.21M |
|
2163
Lightwave Logic
LWLG
$1.04B
| $7.29M | ﹤0.01% |
+490,204
| New | +$6.45M |
|
2164
SiriusPoint
SPNT
$2.74B
| $7.29M | ﹤0.01% |
896,839
+99,975
| +13% | +$881K |
|
2165
V2X
VVX
$2.78B
| $7.27M | ﹤0.01% |
158,873
+31,913
| +25% | +$1.51M |
|
2166
Flywire
FLYW
$2.05B
| $7.26M | ﹤0.01% |
190,675
+112,309
| +143% | +$4.8M |
|
2167
Argan
AGX
$8.37B
| $7.25M | ﹤0.01% |
187,336
+10,023
| +6% | +$419K |
|
2168
Agilon Health
AGL
$1.6B
| $7.22M | ﹤0.01% |
10,695
+753
| +8% | +$458K |
|
|
AMRS
2169
DELISTED
Amyris Inc.
AMRS
| $7.22M | ﹤0.01% |
1,334,417
+63,304
| +5% | +$591K |
|
|
GOEV
2170
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $7.2M | ﹤0.01% |
2,029
+44
| +2% | +$176K |
|
2171
Comtech Telecommunications
CMTL
$50.9M
| $7.18M | ﹤0.01% |
303,146
+1,888
| +0.6% | +$46.3K |
|
2172
Gorman-Rupp
GRC
$2.21B
| $7.17M | ﹤0.01% |
160,849
+1,893
| +1% | +$81K |
|
2173
GDS Holdings
GDS
$6.69B
| $7.14M | ﹤0.01% |
151,410
+366
| +0.2% | +$20.2K |
|
2174
Clean Energy Fuels
CLNE
$412M
| $7.13M | ﹤0.01% |
1,162,890
+12,267
| +1% | +$96.2K |
|
|
MODN
2175
DELISTED
MODEL N, INC.
MODN
| $7.1M | ﹤0.01% |
236,378
+3,452
| +1% | +$108K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.